Exosome Research Products Market

Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024

Report Code: BT 6939 Feb, 2019, by marketsandmarkets.com

[127 Pages Report] The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period. The growth of this market is driven by factors such as the increasing funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.

Exosome Research Products Market

Lung cancer segment to dominate the exosome research products market, by cancer application, during the forecast period

Based on cancer applications, the exosomes market is segmented into lung, prostate, breast, colorectal, and other cancers. In 2018, lung cancer accounted for the largest share of the exosomes market for cancer applications. The large share of this segment can primarily be attributed to factors such as the increasing prevalence of lung cancer, technological advancements in instruments & assays for liquid biopsy, and the growing demand for advanced diagnostic technologies.

Increasing basic research and commercial applications of exosomes to drive the market for kits and reagents segment

Based on products and services, the exosomes market is segmented into kits and reagents, instruments, and services. The kits and reagents segment accounted for the largest market share in 2018. The large share of this segment is attributed to the increasing demand for Liquid Biopsy tests, increasing basic research and commercial applications of exosomes, and the need for reliable and specific diagnostic assays.

Academic & research institutes estimated to be the largest end users of exosome research products in 2018

On the basis of end user, the exosome research products market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. In 2018, the academic & research institutes segment is expected to account for the largest share of the exosome research products market. The growing use of exosomes in cancer and stem cell research, increasing number of cancer and stem cell research projects across the globe, and rising public-private funding for exosome-based research are the major factors driving the growth of this end-user segment

Exosome Research Products Market

North America is expected to be the largest regional market for exosome research products

Market growth in North America, the largest regional market for exosome research products, is primarily driven by the availability of government funding for life sciences research, favorable regulatory environment, increasing focus on exosomes in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research. North America has several national institutes that support biotechnology and life science research activities. The growth of the biotechnology and pharmaceutical industries and growth in the number of cancer cases in the region are also supporting market growth

Key Market Players

The global exosome research products market is highly competitive owing to the presence of several large and small players. Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX Pharmagen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research products industry.

Lonza is one of the prominent players in the exosome research products market. The company offers a robust product portfolio and has a strong geographical presence in this market. The company has more than 40 manufacturing and R&D facilities across the globe. With its wide geographic presence and high production capacity, Lonza delivers quality products across the globe.

Thermo Fisher Scientific is another leading player in the exosome research products market. The company’s strong brand recognition and extensive product portfolio in this market are its key strengths. To maintain its leading position in the market, the company adopts organic as well as inorganic growth strategies such as acquisitions and expansions.

Scope of the report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2017

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Products & Services, applications, end users, and regions

Geographies covered

North America, Asia, Europe, and the Rest of the World

Companies covered

Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX Pharmagen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada)

This report categorizes the exosome research products market into the following segments and subsegments:

Exosome Research Products Market, by Product & Service

  • Kits and Reagents
  • Instruments
  • Services

Exosome Research Products Market, by Application

  • Cancer Applications
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Other Cancers
  • Non-cancer Applications

Exosome Research Products Market, by End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinical Testing Laboratories

Exosome Research Products Market, by Region

  • North America
  • Europe
  • Asia
  • RoW

Recent Developments

  • In 2018, Thermo Fisher Scientific expanded its presence in the US by opening the U.S. Precision Medicine Science Center (PMSC) in Cambridge. This center is aimed to develop analytical workflows to generate precise molecular profiles of patients.
  • In 2017, Lonza acquired HansaBioMed Life Sciences (Estonia). This acquisition was aimed to develop exosomes for next-generation life science applications.
  • In 2018, Lonza established its Collaborative Innovation Center (CIC) in the new Life Science Park in the outskirts of Haifa, Israel. This center focuses on R&D projects of Lonza's Pharma&Biotech segment

Key Questions Addressed by the Report

  • Where will all these developments take the industry in the mid-to-long term?
  • What are the recent trends affecting exosome research products?
  • Who are the key players in the market and how intense is the competition?
  • What are the new application areas of exosomes?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst


Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Market Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 29)
    4.1 Exosomes Market: Overview
    4.2 Exosomes Market, By Application, 2019–2024 (USD Million)
    4.3 Exosome Market Share, By Cancer Applications & Region (2018)
    4.4 Exosome Market, By End User, 2019 vs. 2024 (USD Million)
    4.5 Exosome Market: Geographic Growth Opportunities

5 Market Overview (Page No. - 33)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Funding for Life Sciences Research
                    5.2.1.2 High Global Prevalence of Cancer
                    5.2.1.3 Increasing Interest in Exosome-Based Procedures
           5.2.2 Restraints
                    5.2.2.1 Lack of Skilled Professionals
           5.2.3 Opportunities
                    5.2.3.1 Untapped Emerging Markets
                    5.2.3.2 Growing Interest in Exosome-Based Therapeutics
                    5.2.3.3 Personalized Medicine

6 Exosomes Market, By Product & Service (Page No. - 38)
    6.1 Introduction
    6.2 Kits and Reagents
           6.2.1 Kits and Reagents Segment to Witness the Highest Growth in the Exosomes Market During the Forecast Period
    6.3 Instruments
           6.3.1 Increase in the Number of Diagnostic Laboratories Offering Exosome-Based Tests to Drive the Adoption of Instruments
    6.4 Services
           6.4.1 Exosome Services Aid Oncologists to Detect and Monitor Cancer Biomarkers From A Simple Blood Or Urine Sample

7 Exosomes Market, By Application (Page No. - 43)
    7.1 Introduction
    7.2 Cancer Applications
           7.2.1 Lung Cancer
                    7.2.1.1 Increasing Prevalence of Lung Cancer and Technological Advancements in Instruments & Assays for Liquid Biopsy to Drive Market Growth
           7.2.2 Breast Cancer
                    7.2.2.1 High Prevalence of Breast Cancer and Increasing Awareness to Drive the Market for This Segment
           7.2.3 Prostate Cancer
                    7.2.3.1 Liquid Biopsy Helps Detect Aggressive Prostate Cancer Before Surgery—A Key Factor Driving Market Growth
           7.2.4 Colorectal Cancer
                    7.2.4.1 Increasing Research Activities and Projects Based on Exosomes to Drive the Market for This Segment
           7.2.5 Other Cancers
                    7.2.5.1 Rising Incidence of Cancer and Increasing Research Funding to Drive the Market for This Segment
    7.3 Non-Cancer Applications
           7.3.1 Wide Range of Non-Cancer Applications to Drive Growth in the Demand for Exosomes in This Application Segment

8 Exosomes Market, By End User (Page No. - 53)
    8.1 Introduction
    8.2 Academic & Research Institutes
           8.2.1 Academic & Research Institutes are the Largest End Users in the Exosomes Market
    8.3 Pharmaceutical & Biotechnology Companies
           8.3.1 Significant Developments in Research Activities to Drive Market Growth in This End-User Segment
    8.4 Hospitals & Clinical Testing Laboratories
           8.4.1 Hospitals & Clinical Testing Laboratories Use Exosomes for the Diagnosis of Cancer

9 Exosomes Market, By Region (Page No. - 58)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 High Burden of Cancer and Favorable Public and Private Funding for Research Activities to Drive Market Growth
           9.2.2 Canada
                    9.2.2.1 Availability of Research Funding & Rising Incidence of Cancer to Drive Market Growth
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Presence of A Large Number of Academic Research Institutes to Support Market Growth
           9.3.2 UK
                    9.3.2.1 Growth in the Life Sciences Industry to Drive the Market for Exosomes in the UK
           9.3.3 France
                    9.3.3.1 Government Initiatives to Boost R&D Activities in the Country and High Healthcare Expenditure are the Key Factors Driving Market Growth
           9.3.4 Roe
    9.4 Asia
           9.4.1 China
                    9.4.1.1 Government Initiatives to Strengthen the Biotechnology Industry and the High Prevalence of Cancer are the Major Factors Driving Market Growth
           9.4.2 Japan
                    9.4.2.1 High Prevalence of Cancer and Increasing Healthcare Expenditure are the Key Drivers for the Exosomes Market in the Country
           9.4.3 Rest of Asia
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 96)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Scenario
             10.3.1 Partnerships and Agreements (2016–2019)
             10.3.2 Product Launches (2016–2019)
             10.3.3 Acquisitions (2016–2019)
             10.3.4 Expansions (2016–2019)
     10.4 Competitive Leadership Mapping (2017)
             10.4.1 Vanguards
             10.4.2 Innovators
             10.4.3 Dynamic Players
             10.4.4 Emerging Players

11 Company Profiles (Page No. - 102)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)* 
     11.1 Bio-Techne
     11.2 Thermo Fisher Scientific Inc.
     11.3 System Biosciences (SBI)
     11.4 NX Pharmagen
     11.5 Qiagen N.V.
     11.6 Miltenyi Biotech
     11.7 AMS Biotechnology Ltd.
     11.8 Nanosomix
     11.9 Lonza Group AG
     11.10 Norgen Biotek Corp.
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies. 

12 Appendix (Page No. - 120)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (74 Tables)

Table 1 Global Cancer Incidence, 2018 vs. 2025
Table 2 Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 3 Exosomes Market for Kits and Reagents, By Region, 2017–2024 (USD Million)
Table 4 Exosomes Market for Instruments, By Region, 2017–2024 (USD Million)
Table 5 Exosomes Market for Services, By Region, 2017–2024 (USD Million)
Table 6 Exosomes Market, By Application, 2017–2024 (USD Million)
Table 7 Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 8 Exosomes Market for Cancer Applications, By Region, 2017–2024 (USD Million)
Table 9 Exosomes Market for Lung Cancer Applications, By Region, 2017–2024 (USD Million)
Table 10 Exosomes Market for Breast Cancer Applications, By Region, 2017–2024 (USD Million)
Table 11 Exosomes Market for Prostate Cancer Applications, By Region, 2017–2024 (USD Million)
Table 12 Exosomes Market for Colorectal Cancer Applications, By Region, 2017–2024 (USD Million)
Table 13 Exosomes Market for Other Cancer Applications, By Region, 2017–2024 (USD Million)
Table 14 Exosomes Market for Non-Cancer Applications, By Region, 2017–2024 (USD Million)
Table 15 Exosomes Market, By End User, 2017–2024 (USD Million)
Table 16 Exosomes Market for Academic & Research Institutes, By Region, 2017–2024 (USD Million)
Table 17 Exosomes Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 18 Exosomes Market for Hospitals & Clinical Testing Laboratories, By Region, 2017–2024 (USD Million)
Table 19 Exosomes Market, By Region, 2017–2024 (USD Million)
Table 20 North America: Exosomes Market, By Country, 2017–2024 (USD Million)
Table 21 North America: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 22 North America: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 23 North America: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 24 North America: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 25 US: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 26 US: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 27 US: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 28 US: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 29 Canada: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 30 Canada: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 31 Canada: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 32 Canada: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 33 Europe: Exosomes Market, By Country, 2017–2024 (USD Million)
Table 34 Europe: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 35 Europe: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 36 Europe: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 37 Europe: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 38 Germany: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 39 Germany: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 40 Germany: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 41 Germany: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 42 UK: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 43 UK: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 44 UK: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 45 UK: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 46 France: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 47 France: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 48 France: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 49 France: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 50 Roe: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 51 Roe: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 52 Roe: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 53 Roe: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 54 Asia: Exosomes Market, By Country, 2017–2024 (USD Million)
Table 55 Asia: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 56 Asia: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 57 Asia: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 58 Asia: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 59 China: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 60 China: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 61 China: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 62 China: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 63 Japan: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 64 Japan: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 65 Japan: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 66 Japan: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 67 Roa: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 68 Roa: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 69 Roa: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 70 Roa: Exosomes Market, By End User, 2017–2024 (USD Million)
Table 71 RoW: Exosomes Market, By Product & Service, 2017–2024 (USD Million)
Table 72 RoW: Exosomes Market, By Application, 2017–2024 (USD Million)
Table 73 RoW: Exosomes Market for Cancer Applications, By Type, 2017–2024 (USD Million)
Table 74 RoW: Exosomes Market, By End User, 2017–2024 (USD Million)

List of Figures (34 Figures)

Figure 1 Exosomes Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Exosomes Market, By Product & Service, 2019 vs. 2024 (USD Million)
Figure 8 Exosomes Market, By Application, 2019 (USD Million)
Figure 9 Exosomes Market for Cancer Applications, By Type, 2019 vs. 2024 (USD Million)
Figure 10 Exosomes Market, By End User, 2019 vs. 2024 (USD Million)
Figure 11 Geographical Snapshot of the Exosomes Market
Figure 12 High Global Burden of Cancer & Increasing Funding for Life Science Research are Driving the Growth of the Exosome Market
Figure 13 Non-Cancer Application Segment to Register the Highest Growth During the Forecast Period
Figure 14 Lung Cancer Segment to Account for the Largest Market Share in 2018
Figure 15 Academic & Research Institutes to Hold the Largest Share of the Exosome Market During the Forecast Period
Figure 16 North America is the Fastest-Growing Region in the Exosome Market
Figure 17 Exosomes Market: Drivers, Restraints, and Opportunities
Figure 18 Kits and Reagents Segment Will Continue to Dominate the Exosome Products Market During the Forecast Period
Figure 19 Cancer Applications Segment to Dominate Exosomes Market During the Forecast Period (2019–2024)
Figure 20 Pharmaceutical and Biotechnology Companies Segment to Witness the Highest Growth During the Forecast Period
Figure 21 North America: Exosomes Market Snapshot
Figure 22 US: Cancer Statistics
Figure 23 Canada: Cancer Statistics
Figure 24 Europe: Exosomes Market Snapshot
Figure 25 Asia: Exosomes Market Snapshot
Figure 26 RoW: Exosomes Market Snapshot
Figure 27 Key Developments in the Exosomes Market (Jan 2016-Jan 2019)
Figure 28 Market Evolution Framework
Figure 29 Exosomes Market Ranking Analysis, By Key Player (2017)
Figure 30 MnM Dive-Vendor Comparison Matrix: Exosomes Market
Figure 31 Company Snapshot: Bio-Techne
Figure 32 Company Snapshot: thermo Fisher Scientific
Figure 33 Company Snapshot: Qiagen N.V.
Figure 34 Lonza Group AG: Company Snapshot

This study involved four major activities to estimate the current size of the exosome research products market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the exosome research products market. Secondary sources such as the International Society for Extracellular Vesicles (ISEV), UK Society for Extracellular Vesicles (UKEV), American Society for Exosomes and Microvesicles (ASEMV), Belgian Society for Extracellular Vesicles (BESEV), National Breast Cancer Foundation (NBCF), International Journal of Molecular Sciences, European Association for Cancer Research, Journal of Medical Screening, Cancer Council Australia, Annual Reports, Press Releases, SEC Filings, and Investor Presentations were used. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Exosome Research Products Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the exosome research products market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The exosome research products market generated by leading players has been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global exosome research products market on the basis of products & services, applications, end users, and regions
  • To provide detailed information about the factors influencing market growth (drivers, restraints, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in North America, Europe, Asia, and the Rest of the World
  • To profile key players and comprehensively analyze their product portfolios, market rankings, and core competencies
  • To track and analyze competitive developments, such as acquisitions, product launches, expansions, and agreements in the global exosome research products market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.

The following customization options are available for this report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
BT 6939
Published ON
Feb, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Exosome Research Products Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home